Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-14T22:30:17.128Z Has data issue: false hasContentIssue false
  • English
  • Français

Global public–private partnerships against neglected diseases: building governance structures for effective outcomes

Published online by Cambridge University Press:  01 January 2008

SEBASTIAN BUCKUP
SEBASTIAN BUCKUP*
Affiliation:
Global Partnership Governance Initiative, Switzerland
*
*Correspondence to: Sebastian Buckup, Project Manager, Global Partnership Governance Initiative, 20 Rue de la Filature, 1227 Carouge (Geneva), Switzerland. Email: s.buckup@alumni.lse.ac.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

Focusing on the problem of pharmaceutical R&D for drugs and vaccines against neglected diseases in developing countries, this article argues that the effectiveness of global health partnerships potentially lies in their capacity to address the problem of dual market failures: on a first level they may tackle the poverty induced lack of effective demand for health products which impedes the creation of market-financed innovative products. On a second level, they may help overcoming hold-up problems and underinvestment induced by the complexity of neglected diseases R&D. Yet, organizing transactions within a partnership is not a panacea against these problems: a crucial determinant of success is proper ownership structures. They need to respond to (i) the degree to which the respective parties value the partnership outcome, (ii) the relative importance of the investment of the parties, and (iii) the nature of the partnership outcome. The argument developed in the analysis is built on an integrated framework combining insights from incomplete contracting theory and public goods economics. It is supported by a preliminary statistical analysis of 17 GHPs.

Type
Articles
Information
Health Economics, Policy and Law , Volume 3 , Issue 1 , January 2008 , pp. 31 - 50
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Besley, Timothy and Maitreesh, Ghatak (2001), ‘Government versus private ownership of public goods’, Quarterly Journal of Economics, 116(4):1343–1372.CrossRefGoogle Scholar
Biersteker, Thomas J (1995), ‘The “triumph” of liberal economic ideas in the developing world’, in Stallings, B. (ed.), Global Change, Regional Response, The new International Context of Development.Google Scholar
Brundtland, Gro Harlem (2003), ‘Global health and international security’, Global Governance, 9: 417–423.CrossRefGoogle Scholar
Buse, Kent (2004a), ‘Global health partnerships, increasing their impact by improved governance’, DFID Health Resource Center.Google Scholar
Buse, Kent (2004b), ‘Governing public–private infectious disease partnerships’, Brown Journal of World Affairs, 10(2):225–242.Google Scholar
Buse, Kent and Amalia, Waxman (2001), ‘Public–private health partnerships:a strategy for the WHO’, Bulletin of the World Health Organization, 79(8):748–754.Google Scholar
Buse, Kent and Andrew, Harmer (2004), ‘Power to the partners? The politics of public–private health partnerships’, Development, 47(2):49–56.CrossRefGoogle Scholar
Buse, Kent and Gill, Walt (2000a), ‘Global public–private partnerships:part I – a new development in health?’, Bulletin of the World Health Organization, 78(4):549–561.Google Scholar
Buse, Kent and Gill, Walt (2000b), ‘Global public–private partnerships:part II – what are the health issues for global governance?’, Bulletin of the World Health Organization, 78(5):699–709.Google ScholarPubMed
Buse, Kent and Gill, Walt (2002a), ‘Globalization and multilateral public–private health partnerships:issues for health policy’, in Lee, K.Buse, K.and Fustukian, S. (eds), Health Policy in a Globalizing World, Cambridge:Cambridge University Press.Google Scholar
Buse, Kent and Gill, Walt (2002b), ‘The World Health Organization and global public–private health partnerships:in search of “good” global health governance’, in Reich, M. R. (ed.), Public–Private Partnerships for Public Health, Boston:Harvard University Press.Google Scholar
Coase, Ronald (1937), ‘The Nature of the Firm’, Economica, 4.CrossRefGoogle Scholar
Economist (2006), The Birth of Philanthrocapitalism, Economist print edition, 23 February.Google Scholar
Grossman, Sanford J. and Oliver, D.Hart (1986), ‘The costs and benefits of ownership:a theory of vertical and lateral integration’, The Journal of Political Economy, 94(4):691–719.CrossRefGoogle Scholar
Hart, Oliver, Andrei, Shleifer and Robert, Vishny (1997), ‘The proper scope of government:theory and application to prisons’, Quarterly Journal of Economics, 112(4):1127–1161.CrossRefGoogle Scholar
Hart, Oliver and John, Moore (1990), ‘Property rights and the nature of the firm’, The Journal of Political Economy, 98(6):1119–1158.CrossRefGoogle Scholar
Hirschman, Alberto O. (1970), Exit, Voice, and Loyalty, Responses to Decline in Firms, Organizations, and States, Cambridge, MA:Harvard University Press.Google Scholar
Jayasuriya, Kanishka (2001), ‘Governance, post Washington consensus and the new anti politics’, Southeast Asia Research Centre Working Paper Series 2.Google Scholar
Kaul, Inge and Pedro, Conceição (2006), ‘Why revisit public finance today?’, in Kaul, I. and Conceição, P. (eds), The New Public Finance, Responding to Global Challenges, Oxford University Press.CrossRefGoogle Scholar
Kaul, Inge, Pedro, Conceição, Katell, Le Goulven, and Ronald, U. Mendoza (eds) (2003), Providing Global Public Goods. Managing Globalization, Oxford:Oxford University Press.CrossRefGoogle Scholar
Kettler, Hannah and Adrian, Towse (2001), ‘Public–private partnerships:a report for the WHO Macroeconomic Commission on Health’, CMH Working Paper Series Paper No. WG2:21.Google Scholar
Kickbusch, Ilona and Kent, Buse (2006), ‘Global influences and global responses:international health at the turn of the twenty-first century’, in Merson, M. H.Black, R. E. and Mills, A. J. (eds), International Public Health:Diseases, Programs, Systems, and Policies, Mississauga, Canada:Jones & Bartlett Publishers International.Google Scholar
Moran, Mary (2005a), ‘A breakthrough in R&D for neglected diseases:new ways to get the drug we need’, PLoS Medicine, 2(9).Google Scholar
Moran, Mary (2005b), The New Landscape of Neglected Disease Drug Development, The Wellcome Trust.Google Scholar
Nwaka, Solomon and Ridley, Robert G. (2003), ‘Virtual drug discovery and development for neglected diseases through public–private partnerships’, Nature Reviews. Drug Discovery, 2.CrossRefGoogle ScholarPubMed
Tarabusi, Claudio Casadio, and Graham, Vickery (1998a), ‘Globalization in the pharmaceutical industry:part I’, International Journal of Health Services,2(1):67–105.CrossRefGoogle Scholar
Tarabusi, Claudio Casadio and Graham, Vickery (1998b), ‘Globalization in the pharmaceutical industry:part II’, Journal of International Health Services, 28(2):281–303.CrossRefGoogle Scholar
Widdus, Roy (2001), ‘Public–private partnerships for health:their main targets, their diversity, and their future directions’, Bulletin of the World Health Organization, 79:713–720.Google ScholarPubMed
Woods, Ngaire (1999), ‘Good governance in international institutions’, Global Governance, 5:39–61.CrossRefGoogle Scholar
WHO, Constitution of the World Health Organization, www.who.int.Google Scholar
Young Oran, R. (1992), ‘The effectiveness of international institutions:hard cases and critical variables’, in Rosenau, J. N. and Czempiel, E.-O. (eds), Governance without Government:Order and Change in World Politics, Cambridge:Cambridge University Press.Google Scholar